Digestive System Diseases: Clinical Trials

13 trials for Digestive System Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 suspended. 13 Phase 3, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 313Suspended 13
Phase 25Suspended 5

Follow Digestive System Diseases: new trials by email Literature Review of Digestive System Diseases trials Research Report on Digestive System Diseases

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Methadone as an Alternative Treatment for Children Underdoing HSCT
PCA plus methadone (Experimental), PCA Alone (SOC) - Leukemia, Aplastic Anemia
Phase 3SuspendedUniversity of Texas Southwestern Medical Center602028-01-012025-10-23
Immunotherapy for Advanced Liver Cancer
AlloStim® immunotherapy, FOLFOX regimen, Sorafenib - Hepatocellular Carcinoma
Phase 2 / Phase 3SuspendedMirror Biologics, Inc.1502023-08-012025-10-23
Somatostatin Analogues With Perioperative Antibiotics Versus Prolonged Antibiotics
Somatostatin analog - Pancreatic Diseases
Phase 2 / Phase 3SuspendedMayo Clinic1032020-11-172026-04-03
Postoperative Antimicrobial Prophylaxis Versus Placebo for Infection Prevention in HCC After Liver Resection
postoperative antimicrobial prophylaxis, No postoperative antimicrobial prophylaxis - Hepatocellular Carcinoma, Postoperative Infection
Phase 3SuspendedSun Yat-sen University4582020-09-012020-03-25
A Clinical Study to Evaluate the Efficacy and Safety of Aramchol in Subjects With NASH (ARMOR)
Aramchol free acid, Placebo - Nonalcoholic Steatohepatitis (NASH)
Phase 3SuspendedGalmed Research and Development, Ltd.1572019-09-232026-02-11
Nivolumab in Combination With TACE/TAE for Patients With Intermediate Stage HCC
Nivolumab and TACE/TAE, TACE/TAE - Hepatocellular Carcinoma
Phase 2 / Phase 3SuspendedThe Clatterbridge Cancer Centre NHS Foundation Trust5222019-05-082025-02-26
Pancreatic Duct Stenting to Prevent Postoperative Pancreatic Fistula (POPF) After Distal Pancreatectomy
Boston Scientific or Cook pancreatic duct stents - Pancreatitis
Phase 3SuspendedKaiser Permanente1202015-12-042018-08-02
Acelarin First Line Randomised Pancreatic Study
Acelarin, Gemcitabine - Pancreatic Acinar Carcinoma, Pancreatic Neoplasms
Phase 2 / Phase 3SuspendedThe Clatterbridge Cancer Centre NHS Foundation Trust3282015-12-012019-10-29
Randomized Trial of Primary Surgery Followed Selective Radiochemotherapy for Rectal Cancer With MRI Negative CRM
Rectectomy, Radiotherapy, Capecitabine - Colorectal Neoplasm, Effects of Radiation Therapy
Phase 3SuspendedZhejiang University3502015-10-012022-05-11
Safety and Efficiency of Photodynamic Therapy for Rectal Cancer
Photodynamic therapy - Advanced Rectal Cancer
Phase 2 / Phase 3Suspendedli xiong1002013-08-012013-06-07
Acupuncture for Diabetic Gastroparesis
Acupuncture, placebo/sham acupuncture - Diabetic Gastroparesis
Phase 3SuspendedShaare Zedek Medical Center402009-06-012008-12-16
L-CARnitine in the Palliative Treatment of Advanced PANcreatic Cancer (CARPAN)
L-Carnitine, Placebo - Pancreatic Carcinoma
Phase 3SuspendedUniversity Medicine Greifswald722006-06-012011-04-07
IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer
Campto, Topotesin, TS-1, L-Plat - Metastatic Colorectal Cancer
Phase 3SuspendedHokkaido Gastrointestinal Cancer Study Group2002006-04-012007-11-01

Narrower conditions

Carcinoma, Hepatocellular (3)  ·  Colorectal Neoplasms (2)  ·  Diabetes Mellitus (2)  ·  Neoplasms (2)  ·  Pancreatic Neoplasms (2)  ·  Anemia, Aplastic (1)  ·  Bone Marrow Failure Disorders (1)  ·  Fatigue (1)  ·  Fibrosis (1)  ·  Gastroparesis (1)  ·  Leukemia (1)  ·  Liver Cirrhosis (1)  ·  Liver Neoplasms (1)  ·  Malnutrition (1)  ·  Mucositis (1)

Broader conditions

Digestive System Neoplasms (8)  ·  Neoplasms by Site (8)  ·  Neoplasms (7)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Gastrointestinal Diseases (5)  ·  Endocrine System Diseases (4)  ·  Liver Diseases (4)  ·  Neoplasms by Histologic Type (4)  ·  Signs and Symptoms (4)  ·  Adenocarcinoma (3)  ·  Carcinoma (3)  ·  Gastrointestinal Neoplasms (3)  ·  Intestinal Diseases (3)  ·  Intestinal Neoplasms (3)

Interventions

Oxaliplatin (2)  ·  Acupuncture Therapy (1)  ·  Capecitabine (1)  ·  Carnitine (1)  ·  Fluorouracil (1)  ·  Folfox protocol (1)  ·  Gemcitabine (1)  ·  Hydromorphone (1)  ·  Irinotecan (1)  ·  Leucovorin (1)  ·  Methadone (1)  ·  Morphine (1)  ·  NUC-1031 (1)  ·  Nivolumab (1)  ·  Passive Cutaneous Anaphylaxis (1)

Sponsors

The Clatterbridge Cancer Centre NHS Foundation Trust (2)  ·  Galmed Research and Development, Ltd. (1)  ·  Hokkaido Gastrointestinal Cancer Study Group (1)  ·  Kaiser Permanente (1)  ·  Mayo Clinic (1)  ·  Mirror Biologics, Inc. (1)  ·  Shaare Zedek Medical Center (1)  ·  Sun Yat-sen University (1)  ·  University Medicine Greifswald (1)  ·  University of Texas Southwestern Medical Center (1)  ·  Zhejiang University (1)  ·  li xiong (1)

Countries

China (3)  ·  United States (3)  ·  United Kingdom (2)  ·  France (1)  ·  Germany (1)  ·  Israel (1)  ·  Japan (1)  ·  Malaysia (1)  ·  Thailand (1)

Top investigators

Daniel H Palmer, BSC, PhD (1)  ·  Daniel Palmer, PhD, MD (1)  ·  Joseph Lysy, M.D. (1)  ·  Ke-Feng Ding, M.D. (1)  ·  Louis A DiFronzo, MD (1)  ·  Markus M. Lerch, Prof. (1)  ·  Michael L Kendrick, MD (1)  ·  Noah Samuels, M.D. (1)  ·  Victor M Aquino, MD (1)  ·  Yoshito Komatsu, MD, PhD (1)  ·  Yossi Gilgun-Sherki, PhD, MBA (1)

Results publications

PMID 20510306, PMID 32557715, PMID 38181839, PMID 38916482